BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33668564)

  • 1. A Randomized Controlled Trial on the Effectiveness of Epidermal Growth Factor-Containing Ointment on the Treatment of Solar Lentigines as Adjuvant Therapy.
    Kim HO; Kim HR; Kim JC; Kang SY; Jung MJ; Chang SE; Park CW; Chung BY
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33668564
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of an epidermal growth factor-containing cream on postinflammatory hyperpigmentation after 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser treatment of acquired bilateral nevus of Ota-like macules (Hori's nevus) in Asians: A split-face, double-blinded, randomized controlled study.
    Wattanakrai P; Sindhusen S; Ploydaeng M
    J Cosmet Dermatol; 2022 May; 21(5):2031-2037. PubMed ID: 35066982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective Randomized Controlled Study of Oral Tranexamic Acid for the Prevention of Postinflammatory Hyperpigmentation After Q-Switched 532-nm Nd:YAG Laser for Solar Lentigines.
    Rutnin S; Pruettivorawongse D; Thadanipon K; Vachiramon V
    Lasers Surg Med; 2019 Dec; 51(10):850-858. PubMed ID: 31302943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of removing solar lentigines in Asians using a novel dual-wavelength and dual-pulse width picosecond laser.
    Negishi K; Akita H; Matsunaga Y
    Lasers Surg Med; 2018 Oct; 50(8):851-858. PubMed ID: 29608215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal tranexamic acid injections to prevent post-inflammatory hyperpigmentation after solar lentigo removal with a Q-switched 532-nm Nd:YAG laser.
    Sirithanabadeekul P; Srieakpanit R
    J Cosmet Laser Ther; 2018; 20(7-8):398-404. PubMed ID: 29505310
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of an epidermal growth factor-containing cream on postinflammatory hyperpigmentation after Q-switched 532-nm neodymium-doped yttrium aluminum garnet laser treatment.
    Park GH; Rhee do Y; Moon HR; Won CH; Lee MW; Choi JH; Moon KC; Chang SE
    Dermatol Surg; 2015 Jan; 41(1):131-5. PubMed ID: 25551327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Q-switched Nd: YAG laser and fractional carbon dioxide laser for the treatment of solar lentigines in Asians.
    Vachiramon V; Panmanee W; Techapichetvanich T; Chanprapaph K
    Lasers Surg Med; 2016 Apr; 48(4):354-9. PubMed ID: 27096729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Split-Face, Single-Blinded, Randomized Controlled Comparison of 532 nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser versus 532 nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser in the Treatment of Solar Lentigines.
    Kim JY; Yang J; Huh G; Choi YJ; Kim WS
    Ann Dermatol; 2020 Feb; 32(1):8-13. PubMed ID: 33911703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Q-switched double frequency Nd:YAG 532-nm nanosecond laser vs. double frequency Nd:YAG 532-nm picosecond laser for the treatment of solar lentigines in Asians.
    Vachiramon V; Iamsumang W; Triyangkulsri K
    Lasers Med Sci; 2018 Dec; 33(9):1941-1947. PubMed ID: 29948457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A split-face, evaluator-blind randomized study on the early effects of Q-switched Nd:YAG laser versus Er:YAG micropeel in light solar lentigines in Asians.
    Jun HJ; Kim SM; Choi WJ; Cho SH; Lee JD; Kim HS
    J Cosmet Laser Ther; 2014 Apr; 16(2):83-8. PubMed ID: 24409833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Q-Switched 660-nm Versus 532-nm Nd: YAG Laser for the Treatment for Facial Lentigines in Asian Patients: A Prospective, Randomized, Double-Blinded, Split-Face Comparison Pilot Study.
    Noh TK; Chung BY; Yeo UC; Chang S; Lee MW; Chang SE
    Dermatol Surg; 2015 Dec; 41(12):1389-95. PubMed ID: 26551773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of recombinant human epidermal growth factor containing ointment on wound healing and post inflammatory hyperpigmentation prevention after fractional ablative skin resurfacing: A split-face randomized controlled study.
    Techapichetvanich T; Wanitphakdeedecha R; Iamphonrat T; Phothong W; Eimpunth S; Jane Hidajat I; Manuskiatti W
    J Cosmet Dermatol; 2018 Oct; 17(5):756-761. PubMed ID: 29956440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postinflammatory hyperpigmentation associated with treatment of solar lentigines using a Q-Switched 532-nm Nd: YAG laser: a multicenter survey.
    Kang HJ; Na JI; Lee JH; Roh MR; Ko JY; Chang SE
    J Dermatolog Treat; 2017 Aug; 28(5):447-451. PubMed ID: 27786580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vivo trial comparing the use of different types of 532 nm Nd:YAG lasers in the treatment of facial lentigines in Oriental patients.
    Chan HH; Fung WK; Ying SY; Kono T
    Dermatol Surg; 2000 Aug; 26(8):743-9. PubMed ID: 10940060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prospective Study in the Treatment of Lentigines in Asian Skin Using 532 nm Picosecond Nd:YAG Laser.
    Chan MWM; Shek SY; Yeung CK; Chan HH
    Lasers Surg Med; 2019 Nov; 51(9):767-773. PubMed ID: 31115070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A split-face, evaluator-blind randomized study on the early effects of Q-switched Nd:YAG laser plus Er:YAG micropeel (combined therapy) versus Q-switched Nd:YAG alone in light solar lentigines in Asians.
    Jun HJ; Cho SH; Lee JD; Kim HS
    Lasers Med Sci; 2014 May; 29(3):1153-8. PubMed ID: 24292155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of isobutylamido thiazolyl resorcinol for prevention of laser-induced post-inflammatory hyperpigmentation: A randomized, controlled trial.
    Vachiramon V; Sakpuwadol N; Yongpisarn T; Anuntrangsee T; Palakornkitti P
    J Cosmet Dermatol; 2024 Jul; 23(7):2450-2457. PubMed ID: 38497328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic Melanoma Arising after 1,064 nm q-Switched Nd:YAG Laser of a Suspected Solar Lentigo.
    Cohen L; Nanda S; Zaiac M
    Case Rep Dermatol Med; 2019; 2019():3907671. PubMed ID: 31080677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-fluence Q-switched Nd:YAG 1064-nm laser versus Q-switched Nd:YAG 532-nm laser in the treatment of hyperpigmented lips: a prospective, randomized, controlled, evaluator-blinded trial.
    Limpjaroenviriyakul N; Jurairattanaporn N; Kamanamool N; Rojhirunsakool S; Kanokrungsee S; Udompataikul M
    Lasers Med Sci; 2020 Feb; 35(1):165-171. PubMed ID: 31177406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.